Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Oncology|November 19, 2014
The value of trefoil factor 3 expression in predicting the long‑term outcome and early recurrence of colorectal cancerKiyoto Morito, Jun Nakamura, Yoshihiko Kitajima, et al.
International Journal of Molecular Sciences|July 29, 2023
Suppression of NASH-Related HCC by Farnesyltransferase Inhibitor through Inhibition of Inflammation and Hypoxia-Inducible Factor-1α ExpressionKohei Yamada, Tomokazu Tanaka, Keita Kai, et al.
International Journal of Molecular Sciences|December 30, 2025
Putative Role of Fatty Acid Metabolic Therapy Using Ketogenic Diet and HIF-1α Inhibition in Hepatocellular Carcinoma: Evidence from an In Vitro StudyNaoya Kimura, Yoshihiko Kitajima, Kazuki Higure, et al.
Journal of Cellular Physiology|May 4, 2016
Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In VitroTomokazu Tanaka, Yuichi Ikegami, Harumasa Nakazawa, et al.
International Journal of Oncology|January 8, 2013
Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancerTomokazu Tanaka, Jun Nakamura, Yoshihiko Kitajima, et al.
International Journal of Oncology|August 24, 2013
HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancerShuusuke Miyake, Yoshihiko Kitajima, Jun Nakamura, et al.
BMC Oral Health|December 20, 2024
Characteristics of drugs with oral frailty patients among community pharmacy visitors: a cross-sectional studyAyako Maeda-Minami, Misuzu Takashima, Yukako Morisaki, et al.
Pageof 5